Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8031)
All Articles published online
|
Publishing Process of This Article
|
Nov 7, 2017 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Cho JH, Lim JY, Cho JY. Survival analysis based on human epidermal growth factor 2 status in stage II-III gastric cancer. World J Gastroenterol 2017; 23(41): 7407-7414 [PMID: 29151694 DOI: 10.3748/wjg.v23.i41.7407] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i41/7407.htm |
| Number | Citing Articles |
| 1 |
Imane El Dika, David H. Ilson. Current and future therapies for targeting HER2 mutations in gastrointestinal cancer. Expert Review of Anticancer Therapy 2018; 18(11): 1085 doi: 10.1080/14737140.2018.1510324
|
| 2 |
Ju Yup Lee, Mae-Ja Park. The Role of Serum CD26 in the Diagnosis of Gastric Cancer. International Journal of General Medicine 2022; : 7179 doi: 10.2147/IJGM.S378620
|
| 3 |
Shaohua Ge, Haiyang Zhang, Ting Deng, Wu Sun, Tao Ning, Qian Fan, Yi Wang, Xinyi Wang, Qiumo Zhang, Zhengyang Zhou, Haiou Yang, Guoguang Ying, Yi Ba. MiR-181a, a new regulator of TGF-β signaling, can promote cell migration and proliferation in gastric cancer. Investigational New Drugs 2019; 37(5): 923 doi: 10.1007/s10637-018-0695-5
|
| 4 |
Qiong Shao, Fang Wang, Yuxia Xu, Xu Zhang, Wenting Tang, Yanfen Feng, Yue Li, Anil K Verma. CDKL2 Is Associated with HER2 Status and Overall Survival in Gastric Cancer: Comparative Analysis of CDKL2 Protein Expression and Gene Copy Number. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/1712723
|
| 5 |
Konstantin Koro, Paul E. Swanson, Matthew M. Yeh. HER2 Testing in Gastric and Gastroesophageal Adenocarcinoma—Review and Update. AJSP: Reviews and Reports 2019; 24(4): 179 doi: 10.1097/PCR.0000000000000322
|
| 6 |
Khalil El Gharib, Makram Khoury, Hampig Raphael Kourie. HER2 in Gastric Adenocarcinoma: Where Do we Stand Today?. Personalized Medicine 2022; 19(1): 67 doi: 10.2217/pme-2021-0004
|
| 7 |
Jaffer A. Ajani, Thomas A. D’Amico, David J. Bentrem, Joseph Chao, David Cooke, Carlos Corvera, Prajnan Das, Peter C. Enzinger, Thomas Enzler, Paul Fanta, Farhood Farjah, Hans Gerdes, Michael K. Gibson, Steven Hochwald, Wayne L. Hofstetter, David H. Ilson, Rajesh N. Keswani, Sunnie Kim, Lawrence R. Kleinberg, Samuel J. Klempner, Jill Lacy, Quan P. Ly, Kristina A. Matkowskyj, Michael McNamara, Mary F. Mulcahy, Darryl Outlaw, Haeseong Park, Kyle A. Perry, Jose Pimiento, George A. Poultsides, Scott Reznik, Robert E. Roses, Vivian E. Strong, Stacey Su, Hanlin L. Wang, Georgia Wiesner, Christopher G. Willett, Danny Yakoub, Harry Yoon, Nicole McMillian, Lenora A. Pluchino. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 2022; 20(2): 167 doi: 10.6004/jnccn.2022.0008
|
| 8 |
Moonsik Kim, An Na Seo. Molecular Pathology of Gastric Cancer. Journal of Gastric Cancer 2022; 22(4): 264 doi: 10.5230/jgc.2022.22.e35
|
| 9 |
Sun Ah Jeong, Jung Min Choi, Jun Mo Park, Jun Young Lee, So Jung Lee, Su Yeon Lee, Si Yeon Lee, Yoon A Park, Hee Jeong Jeong, Yoo Cheol Song, Sung Hwan Kim, Shin Jae Chang. Mechanism of action of the trastuzumab biosimilar CT-P6. Expert Opinion on Biological Therapy 2019; 19(10): 1085 doi: 10.1080/14712598.2019.1554052
|
| 10 |
Li Zhang, Virginia Aragon‐Sanabria, Anusha Aditya, Marcello Marelli, Tianye Cao, Feng Chen, Barney Yoo, Kai Ma, Li Zhuang, Thais Cailleau, Luke Masterson, Melik Z. Turker, Rachel Lee, Gabriel DeLeon, Sebastien Monette, Raffaele Colombo, Ronald J. Christie, Pat Zanzonico, Ulrich Wiesner, J. Anand Subramony, Michelle S. Bradbury. Engineered Ultrasmall Nanoparticle Drug‐Immune Conjugates with “Hit and Run” Tumor Delivery to Eradicate Gastric Cancer. Advanced Therapeutics 2023; 6(3) doi: 10.1002/adtp.202200209
|
| 11 |
Ji Cheng, Ming Cai, Guobin Wang, Kaixiong Tao. HER2 becomes a novel survival biomarker for gastric cancer patients: a pooled analysis. Therapeutic Advances in Medical Oncology 2024; 16 doi: 10.1177/17588359241271913
|